Biolife Solutions BLFS
NASDAQ BLFS
$37.10 +0.13 (+0.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biolife Solutions (BLFS) Asset Writedowns and Impairment (2016 - 2023)

Biolife Solutions (BLFS) posted quarterly Asset Writedowns and Impairment of $1.4 million for Q4 2023, up 102.03% year-over-year from $701390.8 in Q4 2022, and down 82.95% quarter-over-quarter from $8.3 million in Q3 2023.

Biolife Solutions (BLFS) Asset Writedowns and Impairment (2016 - 2023) Analysis & Trends

Biolife Solutions (BLFS) has reported Asset Writedowns and Impairment for 4 consecutive years, with $1.4 million the latest figure, recorded in Q4 2023.

  • In Q4 2023, Asset Writedowns and Impairment rose 102.03% year-over-year to $1.4 million; the TTM figure through Dec 2024 stood at $9.7 million (up 116.17% YoY), while the FY2023 annual figure was $9.7 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment fell to $1.4 million in Q4 2023 per BLFS's latest filing, from $8.3 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $69.9 million in Q2 2022 and bottomed at -$69.9 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Biolife Solutions 1.82 Bn 1.73 Bn 18.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 1.42 Mn
Dec 31, 2023 1.42 Mn
Sep 30, 2023 8.31 Mn
Sep 30, 2023 8.31 Mn
Dec 31, 2022 -69.90 Mn
Dec 31, 2022 -69.90 Mn
Jun 30, 2022 69.90 Mn
Jun 30, 2022 69.90 Mn
Dec 31, 2017 336.00
Dec 31, 2017 336.00
Sep 30, 2017 67,664.00
Sep 30, 2017 67,664.00
Jun 30, 2016 86,736.00
Jun 30, 2016 86,736.00